Grants per year
Fingerprint Dive into the research topics where Gary E Schiltz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Ligands
Medicine & Life Sciences
HIV Protease Inhibitors
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
Chemical Compounds
Protease Inhibitors
Chemical Compounds
Scaffolds
Chemical Compounds
Assays
Chemical Compounds
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2011 2024
Development of Novel MNK Inhibitors for Treating Glioblastoma
Clutter, M., Eckerdt, F. D., Horbinski, C. M., James, C. D., Mishra, R. K., Platanias, L. C. & Schiltz, G. E.
National Institute of Neurological Disorders and Stroke
9/1/19 → 6/30/24
Project: Research project
Glioblastoma
Stem Cells
Phosphotransferases
Cell Survival
Survival
DART2.0: comprehensive cell type-specific behavioral neuropharmacology
Duke University, National Institute of Mental Health
9/14/18 → 9/13/21
Project: Research project
Neuropharmacology
Pharmaceutical Preparations
Ligands
Technology
Neurobiology
Subproject for SP0046885 Luo Core B
Jin, J., Kandela, I., Luo, X., Mathew, J., Schiltz, G. E., Scott, E. A., Vanoye, C. G. & Wertheim, J. A.
National Institute of Diabetes, Digestive and Kidney Diseases
8/1/18 → 7/31/23
Project: Research project
Kidney
Kidney Diseases
Research Personnel
Therapeutics
Nanomedicine
Discovery of novel small molecule antidepressants
Clutter, M., Mishra, R. K. & Schiltz, G. E.
Vanderbilt University, National Institute of Mental Health
2/1/18 → 1/31/20
Project: Research project
Antidepressive Agents
High-Throughput Screening Assays
Manuscripts
Organized Financing
Research
Targeting chemokine signaling and MAPK/ERK pathway in advanced prostate cancer
Yu, J., Cristofanilli, M., Hussain, M., Miller, R. J., Schiltz, G. E., Yang, X. J., Zhang, B. & Zhao, C.
12/31/17 → 12/31/19
Project: Research project
CXC Chemokines
MAP Kinase Signaling System
Chemokine Receptors
Chemokines
Prostatic Neoplasms
Research Output 2001 2019
Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands
Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., Jul 3 2019, In : ChemMedChem. 14, 13, p. 1248-1256 9 p.Research output: Contribution to journal › Article
Drug Discovery
Ligands
Central Nervous System Diseases
Neurology
Solubility
2
Citations
(Scopus)
Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands
Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., May 1 2019, In : Bioorganic and Medicinal Chemistry. 27, 9, p. 1824-1835 12 p.Research output: Contribution to journal › Article
Protein Transport
Ligands
Molecular modeling
Central Nervous System Diseases
Structure-Activity Relationship
Palladium-Catalyzed Coupling Reactions on Functionalized 2-Trifluoromethyl-4-chromenone Scaffolds: Synthesis of Highly Functionalized Trifluoromethyl Heterocycles
Izquierdo, J., Jain, A. D., Abdulkadir, S. A. & Schiltz, G. E., Jan 1 2019, In : Synthesis (Germany). 51, 6, p. 1342-1352 11 p.Research output: Contribution to journal › Article
Fluorine
Palladium
Bioactivity
Biological Products
Scaffolds
1
Citation
(Scopus)
Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia
Zhao, Z., Wang, L., Volk, A. G., Birch, N. W., Stoltz, K. L., Bartom, E. T., Marshall, S. A., Rendleman, E. J., Nestler, C. M., Shilati, J., Schiltz, G. E., Crispino, J. D. & Shilatifard, A., Jan 1 2019, In : Genes and Development. 33, 1-2, p. 61-74 14 p.Research output: Contribution to journal › Article
Aspartate Ammonia-Lyase
Threonine
Leukemia
Casein Kinase II
Therapeutics
Small molecules target the interaction between tissue transglutaminase and fibronectin
Sima, L. E., Yakubov, B., Zhang, S., Condello, S., Grigorescu, A. A., Nwani, N. G., Chen, L., Schiltz, G. E., Arvanitis, C., Zhang, Z. Y. & Matei, D. E., Jan 1 2019, In : Molecular cancer therapeutics. 18, 6, p. 1057-1068 12 p.Research output: Contribution to journal › Article
Fibronectins
Ovarian Neoplasms
Cell-Matrix Junctions
Interferometry
Focal Adhesion Protein-Tyrosine Kinases